|
Title
|
Published
|
Price
|
|
Freedonia Focus on Cancer Therapies
By: Freedonia Focus
This report discusses US demand for cancer therapies for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, types of cancer, diagnosis and screening, technology
|
more...
|
11/30/2009
|
$500.00
|
|
Chiropractor Offices
By: First Research, Inc.
The US chiropractic industry includes about 36,000 businesses and 60,000 licensed chiropractors with combined annual revenue of nearly $10 billion. No major companies dominate. The industry is highly fragmented: the top 50 chiropractor offices generate
|
more...
Search inside this report
|
11/9/2009
|
$129.00
|
|
Prostate Cancer Drug Discoveries: What the Future Holds
By: Espicom Healthcare Intelligence
Prostate cancer is the second leading cause of cancer in the US and the third most common cancer worldwide. More than two million men in the US suffer with prostate cancer. Find out more about
|
more...
Search inside this report
|
11/5/2009
|
$2,460.00
|
|
Dealmaking and Industry Outlook: Neurological Disease
By: Decision Resources
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying
causes of these diseases are far from certain; as a result, therapeutic strategies in effect today may
|
more...
|
11/2/2009
|
$2,250.00
|
|
Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
By: Kalorama Information
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready?
|
more...
Search inside this report
|
11/1/2009
|
$3,995.00
|
|
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
By: MarketsandMarkets
REPORT DESCRIPTION
H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009. The
|
more...
Search inside this report
|
11/1/2009
|
$4,650.00
|
|
DiseaseINFOPACK: Clostridium difficile in China
By: VacZine Analytics
Clostridium difficile (C.diff) is a Gram-positive bacterium, which in vulnerable hospitalized patients can cause mild uncomplicated diarrhea to severe-complicated disease where patients experience fever, tachycardia and psuedomembranous colitis. While information and literature pertaining to C.diff
|
more...
|
11/1/2009
|
$4,895.00
|
|
Competitor Analysis: TGF-R Agonists and Antagonists
By: La Merie S.L.
The present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TGF targeting molecules for tissue healing or treatment of cancer and
|
more...
|
11/1/2009
|
$297.00
|
|
Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies
By: Venture Planning Group
The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces
|
more...
|
11/1/2009
|
$25,800.00
|
|
Gastrointestinal (GI) Endoscopy Devices Worldwide
By: MarketStrat, Inc.
The purpose of this report is to analyze and size the world market for GI Endoscopy Devices and accessories, discuss key players and identifies trends impacting the market for these products. Topics covered include product
|
more...
|
11/1/2009
|
$2,995.00
|
|
CDK Inhibitors Patent Landscape 2009
By: France Innovation Scientifique et Transfer
IP Overview presents a patent landscape analysis of the CDK Inhibitor field.
Alterations in CDK activity have been associated in the development of viral infections, neurodegenerative dis orders such as Alzheimer’s disease and proliferative
|
more...
Search inside this report
|
10/29/2009
|
$1,645.00
|
|
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
By: BioSeeker Group AB
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of
|
more...
|
10/29/2009
|
$3,500.00
|
|
Antipsychotics Market Forecast
By: Datamonitor
Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is
|
more...
|
10/28/2009
|
$15,200.00
|
|
Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion
By: Datamonitor
Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is
|
more...
|
10/28/2009
|
$15,200.00
|
|
Substance Abuse & Mental Health Clinics in the US - Industry Market Research Report
By: IBISWorld
Industry Market Research Synopsis This Industry Market Research report from IBISWorld provides a detailed analysis of the Substance Abuse & Mental Health Clinics in the US industry, including key growth trends, statistics, forecasts, the competitive environment
|
more...
Search inside this report
|
10/21/2009
|
$825.00
|
|
Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine
By: Datamonitor
Introduction CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there
|
more...
|
10/21/2009
|
$11,400.00
|
|
Abortion Clinics, Fertility & Family Planning Centers in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Abortion Clinics, Fertility & Family Planning Centers in the US industry. Industry Risk is assumed to be 'the
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Substance Abuse & Mental Health Facilities in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Substance Abuse & Mental Health Facilities in the US industry. Industry Risk is assumed to be 'the difficulty,
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Substance Abuse & Mental Health Clinics in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Substance Abuse & Mental Health Clinics in the US industry. Industry Risk is assumed to be 'the difficulty,
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Psychiatric Hospitals in Australia - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Psychiatric Hospitals in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
|
more...
Search inside this report
|
10/17/2009
|
$810.00
|
|
Dental Services in Australia - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Dental Services in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
|
more...
Search inside this report
|
10/17/2009
|
$810.00
|
|
Elderly & Disabled Services in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Elderly & Disabled Services in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise,
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Dentists in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Dentists in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
|
more...
Search inside this report
|
10/17/2009
|
$825.00
|
|
Japanese Market for Women's Health Devices 2009
By: iData Research, Inc.
The Japanese Market for Women’s Health Devices includes the markets for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, assisted reproduction, endometrial resection devices, hysteroscopes, colposcopes, female urinary incontinence slings, pelvic reconstruction devices and
|
more...
|
10/15/2009
|
$7,495.00
|
|
Orthopedics: Global Industry Guide
By: Datamonitor
Datamonitor's Orthopedics: Global Industry Guide is an essential resource for top-level data and analysis covering the Orthopedics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive
|
more...
Search inside this report
|
10/14/2009
|
$995.00
|
|
Title
|
Published
|
Price
|
(0 items)
